Scope of this article
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
This translation is provided for general access and has no recorded medical-language review.
Editorial general information — not a clinical-review record
Published: Updated: Publisher: Dr. Murat Toktamışoğlu
Using a dermal filler designed for a facial indication in the buttocks, breasts, between muscles or for large-volume body enhancement is not the same indication. FDA states that no dermal filler or injectable silicone is approved for large-scale body contouring and warns of embolism, infection, tissue death, permanent disfigurement and death.
This translation has no recorded clinical or medical-language review.
Regulatory assessment concerns a particular product, volume range, anatomical area, age group and technique. Authorization for a facial fold or the back of the hand does not establish body safety. Large volume changes the scale of intravascular entry, migration, infectious burden, chronic inflammation and difficulty of surgical removal.
A breast implant contains silicone within a shell; freely injected liquid silicone can migrate through tissue. Industrial or unidentified substances are not medical fillers. Injections from unlabeled containers in a hotel, home or nonmedical setting add hazards involving sterility, product verification and access to emergency care.
Shortness of breath, chest pain, sudden weakness, speech difficulty, severe headache or altered consciousness requires emergency help. Later pain, hardness, drainage, colour change or suspected migration warrants specialist assessment with the product name, amount, date, site and available records. Blind dissolution or removal should not be attempted before the material is identified.
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
These links are editorial starting points used to examine the article's boundaries.
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
U.S. Food and Drug Administration · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
G. S. G. Inocêncio et al. · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
S. M. Shridharani and M. L. Kennedy · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
U.S. Food and Drug Administration (FDA) · 2026
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
FDA device labeling / Merz North America · 2026
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review